HELIXBIND
HelixBind is a Massachusetts-based company that operates in the biotechnology sector. The company was founded in 2012 and is based in Worcester, Massachusetts.
HELIXBIND
Industry:
Biotechnology Medical Medical Device
Founded:
2012-01-01
Address:
Worcester, Massachusetts, United States
Country:
United States
Website Url:
http://www.helixbind.com
Total Employee:
11+
Status:
Active
Total Funding:
22.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Sectigo SSL Sectigo Domain SSL PostalAddress Schema LocalBusiness Schema
Similar Organizations
Lazurite
Lazurite is a biotechnology company that creates the operating room of the future through smart surgical tools.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Helixbind
National Institutes of Health
National Institutes of Health investment in Grant - Helixbind
CARB-X
CARB-X investment in Grant - Helixbind
CARB-X
CARB-X investment in Grant - Helixbind
National Institutes of Health
National Institutes of Health investment in Grant - Helixbind
National Institutes of Health
National Institutes of Health investment in Grant - Helixbind
National Institutes of Health
National Institutes of Health investment in Grant - Helixbind
National Science Foundation
National Science Foundation investment in Grant - Helixbind
Official Site Inspections
http://www.helixbind.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Helixbind"
COMPANY | HelixBind
Together we can reduce the spread of antimicrobial resistance, improve outcomes, and save lives.See details»
Helixbind - Crunchbase Company Profile & Funding
Organization. Helixbind . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... HelixBind is a Massachusetts-based company that operates in the biotechnology sector. The …See details»
HelixBind, Inc - LinkedIn
HelixBind, Inc | 1,966 followers on LinkedIn. Revolutionizing care for invasive infections such as sepsis | HelixBind is working to revolutionize care for invasive infections such as sepsis. Our ...See details»
Helixbind Company Profile 2024: Valuation, Funding
Helixbind General Information Description. Developer of a pathogen identification platform designed to detect bloodstream infections. The company's pathogen identification platform offers rapid detection and unequivocal identification of …See details»
HelixBind - Overview, News & Similar companies | ZoomInfo.com
Aug 23, 2020 HelixBind Awarded $3MM NIH Grant to Support Testing of Its RaPID Diagnostic Platform for Invasive Infections Associated with Sepsis BOXBOROUGH, Mass., June 17, 2021 …See details»
Helixbind - Funding, Financials, Valuation & Investors
HelixBind is a Massachusetts-based company that operates in the biotechnology sector. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How much funding has this organization raised over …See details»
Helixbind, Inc. Company Profile | Boxborough, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Helixbind, Inc. of Boxborough, MA. Get the latest business insights from Dun & Bradstreet.See details»
HelixBind Company Profile - Office Locations, Competitors ... - Craft
HelixBind has 5 employees at their 1 location and $1.7 m in total funding,. See insights on HelixBind including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
CARB-X teams up with HelixBind to support the development of a …
Mar 15, 2018 Helixbind’s Rapid/BSI Diagnostic Test Would Enable Doctors to Diagnose and Treat Deadly Bacterial Infections More Quickly and Effectively Than is Possible With Today’s …See details»
FDA Grants HelixBind Breakthrough Device Designation ... - Yahoo …
Aug 24, 2020 HelixBind’s device identifies the most common bloodstream infections associated with sepsis direct from blood and is designed to reduce time-to-diagnosis from days to …See details»
HelixBind Awarded $3MM Grant from NIH and Expands Clinical
Jun 10, 2020 HelixBind is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis. Its novel platform provides faster, more accurate, and more …See details»
How HelixBind Inc. is translating sepsis diagnostics to Lyme disease
May 1, 2023 Sepsis is a global health crisis; without prompt care, sepsis can lead to death. HelixBind Inc. has developed a rapid test to identify early infection in the blood, receiving …See details»
HelixBind Awarded $3MM NIH Grant to Support Testing of Its …
BOXBOROUGH, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, …See details»
HelixBind Awarded $2M in CARB-X Funding for Culture-Free BSI …
Mar 15, 2018 The organization will specifically fund innovative antibiotics and other therapeutics, vaccines, rapid diagnostics, and devices to treat drug-resistant bacterial infections. …See details»
FDA Grants HelixBind Breakthrough Device Designation for
Aug 24, 2020 HelixBind’s submission to the FDA focused on the features of the RaPID platform that distinguish the test from the current standard of care, and meet the criteria for the …See details»
Study Demonstrates the Potential of HelixBind’s RaPID/BSI
Feb 12, 2024 HelixBind, Inc. is a developer and manufacturer of in-vitro molecular diagnostic products. The company’s proprietary RaPID (Resistance and Pathogen IDentification) platform …See details»
NEWS - HelixBind
HelixBind announces $9 million in non-dilutive financing from the NIH in 2022 to support the . development of assays for the direct detection and identification of infections. November 2022 …See details»
Products - Helixbind
Together we can reduce the spread of antimicrobial resistance, improve outcomes, and save lives.See details»
Our Technology - HelixBind
HelixBind has embedded the entire process onto a disposable plastic cassette. Everything has been automated, all the user has to do is snap the specimen tube into the cassette and load …See details»